Ticker League

EBITDA Margin for West Pharmaceutical Services (WST)

As of · Reported

Metric

TTM

24.8%

YoY change

−2.17pp

Trough year (1991)

7.0%

Peak year (2021)

31.1%

EBITDA Margin history chart for West Pharmaceutical Services (WST) from 1985 to 2025

Latest: 23.5%

EBITDA Margin change chart for West Pharmaceutical Services (WST) from 1985 to 2025

Latest: −2.17pp

EBITDA Margin history table for West Pharmaceutical Services (WST) from 1985 to 2025

  • 202523.5%-2.17pp
  • 202425.7%-2.89pp
  • 202328.6%+0.60pp
  • 202228.0%-3.07pp
  • 202131.1%+6.91pp
  • 202024.2%+2.30pp
  • 201921.9%+1.31pp
  • 201820.6%+0.17pp
  • 201720.4%+1.37pp
  • 201619.0%+3.44pp
  • 201515.6%-4.02pp
  • 201419.6%+1.16pp
  • 201318.4%+2.64pp
  • 201215.8%+0.41pp
  • 201115.4%+0.78pp
  • 201014.6%-1.16pp
  • 200915.8%-1.94pp
  • 200817.7%+2.27pp
  • 200715.4%-0.97pp
  • 200616.4%-1.15pp
  • 200517.6%+0.12pp
  • 200417.4%+0.17pp
  • 200317.3%-2.45pp
  • 200219.7%+0.91pp
  • 200118.8%+1.17pp
  • 200017.6%-4.12pp
  • 199921.8%+0.20pp
  • 199821.6%+0.84pp
  • 199720.7%+2.42pp
  • 199618.3%-0.56pp
  • 199518.9%-0.36pp
  • 199419.2%+1.13pp
  • 199318.1%-0.62pp
  • 199218.7%+11.68pp
  • 19917.0%-6.54pp
  • 199013.6%-4.69pp
  • 198918.3%+1.16pp
  • 198817.1%-1.33pp
  • 198718.4%-0.88pp
  • 198619.3%+0.64pp
  • 198518.7%—

EBITDA Margin values are taken from West Pharmaceutical Services's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About EBITDA Margin at West Pharmaceutical Services (WST)

According to West Pharmaceutical Services's latest reported financial statements, the company's latest reported EBITDA margin is 24.8%. EBITDA margin is EBITDA divided by revenue — earnings before interest, taxes, depreciation, and amortization as a percentage of sales. By stripping out non-cash charges and capital-structure effects, it approximates operating cash profitability and is widely used to compare companies with different asset bases and leverage.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

In 2025, West Pharmaceutical Services (WST) EBITDA margin totalled 23.54% – contracted 2.2 percentage points year-over-year.

The highest annual EBITDA margin of 31.08% was reported in 2021. The lowest in the available history was 7.04% in 1991.

West Pharmaceutical Services EBITDA Margin by Year

West Pharmaceutical Services EBITDA Margin 2025: 23.5%

In 2025, West Pharmaceutical Services reported EBITDA margin of 23.54%, contracted 2.2 percentage points from 2024.

West Pharmaceutical Services EBITDA Margin 2024: 25.7%

West Pharmaceutical Services EBITDA margin in 2024 was 25.71%, contracted 2.9 percentage points from 2023.

West Pharmaceutical Services EBITDA Margin 2023: 28.6%

2023's EBITDA margin for West Pharmaceutical Services came in at 28.60%, expanded 0.6 percentage points from 2022.

West Pharmaceutical Services EBITDA Margin 2022: 28.0%

West Pharmaceutical Services posted EBITDA margin of 28.01% in 2022, contracted 3.1 percentage points from 2021.

West Pharmaceutical Services EBITDA Margin 2021: 31.1%

West Pharmaceutical Services EBITDA margin in 2021 was 31.08%.

See more financial history for West Pharmaceutical Services (WST).

Sector peers by EBITDA Margin

Healthcare peers of West Pharmaceutical Services (WST), ranked by their latest EBITDA margin

Frequently asked questions

West Pharmaceutical Services (WST) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation

Overview